HIMS & HERS HEALTH INCHIMS

discovered
Neutral

ASignal's systematic analysis rates HIMS as Neutral.

Reflects the latest available analysis · analyzed Oct 1, 2026

The case on HIMS

Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.

Bull case
  • Revenue growth of 38.2% YoY indicates strong top-line expansion
  • Gross margin of 69.53% reflects strong pricing power and low production costs
  • Free cash flow of $849.44M is robust and positive
  • MACD histogram is expanding positively, signaling strengthening momentum
  • Price above 20-day and 50-day SMAs suggests short-term uptrend
VS
Bear case
  • Negative operating margin (-12.75%) and net margin (-5.51%) indicate ongoing profitability challenges
  • Negative return on equity (-32.03%) and return on assets (-2.21%) reflect poor capital efficiency
  • High debt-to-equity ratio of 4.77x raises financial risk concerns
  • Current ratio of 0.93x suggests potential liquidity pressure
  • Forward P/E of 40.41x and P/B of 21.45x indicate expensive valuation relative to fundamentals
Subscriber-only

See the full verdict on HIMS

ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.

How ASignal analyzes HIMS

Most investors never get a second opinion, let alone several. ASignal runs HIMS past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.

The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.

HIMS & HERS HEALTH INC (HIMS) Stock Analysis - ASignal rates it Neutral